Back
SPDR® Portfolio Emerging Markets ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
71
SPEM
SPDR® Portfolio Emerging Markets ETF
Last Price:
37.87
Seasonality Move:
0.89%
Sell
40
PTCT
PTC Therapeutics
Last Price:
30.41
Seasonality Move:
8.11%
Buy
71
SPDR® Portfolio Emerging Markets ETF (SPEM)
is a Buy
Is SPDR® Portfolio Emerging Markets ETF a Buy, Sell or Hold?
- The current SPDR® Portfolio Emerging Markets ETF [SPEM] share price is $37.74. The Score for SPEM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- SPEM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $31.17. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPEM Stock Price Chart
What is SPDR® Portfolio Emerging Markets ETF's stock price today?
-
The SPDR® Portfolio Emerging Markets ETF share price today is $37.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPEM is experiencing selling pressure, which indicates risk of future bearish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $31.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing slight buying pressure.
SPEM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 50.26 | Buy |
Chaikin Money Flow: | -929524 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.43 - 38.07) | Sell |
Bollinger Bands (100): | (35.61 - 37.77) | Buy |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.53 | Sell |
Relative Strength Index (14 RSI): | 37.27 | Sell |
Chaikin Money Flow: | 51415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34 - 37.72) | Sell |
Bollinger Bands (100): | (26.7 - 35.2) | Buy |
SPEM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.82 | Sell |
20-day SMA: | 37.74 | Sell |
50-day SMA: | 37.54 | Buy |
200-day SMA: | 35.39 | Buy |
8-day EMA: | 37.75 | Sell |
20-day EMA: | 37.77 | Sell |
50-day EMA: | 37.45 | Buy |
200-day EMA: | 35.99 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.02 | Sell |
20-day SMA: | 35.78 | Sell |
50-day SMA: | 33.9 | Sell |
200-day SMA: | 27.61 | Buy |
8-day EMA: | 33.59 | Sell |
20-day EMA: | 34.77 | Sell |
50-day EMA: | 33.84 | Sell |
200-day EMA: | 31.82 | Sell |
SPDR® Portfolio Emerging Markets ETF Earnings Growth & SPEM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.
SPDR® Portfolio Emerging Markets ETF Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |